Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases
✍ Scribed by Arnold, W. ;Hess, G. ;Purcell, R. H. ;Kaplan, P. M. ;Gerin, J. L. ;Meyer zum B�schenfelde, K. H.
- Publisher
- Springer-Verlag
- Year
- 1978
- Tongue
- English
- Weight
- 801 KB
- Volume
- 56
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The liver histology of 68 consecutive anti‐HCV/HCV‐RNA positive chronic hepatitis patients who were HBsAg/anti‐HBs negative, anti‐HBc positive (Case bC group) was compared with that of 68 anti‐HCV/HCV‐RNA positive chronic hepatitis patients who were HBsAg/anti‐HBc negative (control C gr
To evaluate the clinical implication of IgM antibody against hepatitis B core antigen (anti-HBc IgM), a consecutive series of 87 patients with acute type B hepatitis and 16 healthy carriers of hepatitis B surface antigen (HBsAg) were studied by a newly developed reverse ELISA technique. Anti-HBc Ig
## Abstract Intrahepatic expression of HBcAg and hepatitis delta antigen (HDAg) was studied in 43 patients with acute exacerbation AE and 37 with chronic active liver disease CALD, in order to evaluate the role of hepatitis B virus (HBV) replication and hepatitis delta virus (HDV) superinfection in